Aristotle University Of Thessaloniki (AUTH)
Μελέτη της καρδιοαναπνευστικής λειτουργίας μετά χορήγηση σαλμετερόλης σε ασθματικά παιδιά
Abstract
dc:descriptionA randomized, open crossover study to compare the protective effect of a single dose of salmeterol delivered via the MDPI and sodium cromoglycate delivered via the spinhaler inhaler against EIA was performed in the Respiratory Laboratory of the Third Department of Pediatrics, University of Thessaloniki. Also we assessed the the tolerability and safety of salmeterol by adverse event monitoring and holter monitoring. Finally we compared the handling of a new device for administering b2 -agonists the Multi Dose Powder Inhaler (MDPI) versus the Spinhaler inhaler.The study was conducted with outpatients between 30/6/94 and 30/1/95. After a preliminary screening visit to establish eligibility to take part in the study patients who participated the study were divided in two groups. One control group with 6 children, 4 boys and 2 girls, who had 2 treadmill tests one in the morning and the second ten hours later, so as to be seen the reproducibility of EIA in different time during the same day. The study group consisted of 20 children, 16 boys and 4 girls, who were subdivided in two groups depending which treatment is administered first.Patients were studied on two separate study days (with 24 hours between visits) and they had exercise tests 1, 4, 6 and 10 hours after the inhalation of the treatment, one dose 50μg Salmeterol with MDPI the first day and 20 mg sodium cromoglycate with Spinhaler inhaler for group 1. The patients of group 2 studied the same way but the two treatments were given vice versa. The respiratory assessment was made with spirometer before and after the treadmill test for 60 minutes. A fall of FEV1 15% or more was the criterion for EIA. Before the study was evaluated the device handling by frequencies of the number of patients requiring further tuition in each of the handling man oeuvres. Safety assessments consisted of adverse event monitoring and pulse rate and rhythm monitoring with holter.There was a significant statistical difference (p<0,001) in favor of salmeterol compared with sodium cromoglycate for the percent fall in FEV1 at 4, 6 and 10 hour post-study treatment challenges. For device handling there was a significant advantage in favor of MDPI compared with spinhaler inhaler. Holter monitoring didn’t show a significant difference between the two treatments at any of the post-study treatment challenges. No serious adverse effect was present and it seems to be salmeterol equally safe with sodium cromoglycate
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 1999
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zampouridis, Aristeidis
- Ζαμπουρίδης, Αριστείδης
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28891